---
schema_version: "secwatch.filing_event.v1"
accession: "0001104659-25-025547"
form_type: "8-K"
ticker: "MIST"
cik: "0001408443"
company_name: "Milestone Pharmaceuticals Inc."
filed_at: "2025-03-19T23:59:59+00:00"
generated_at: "2026-05-24T11:37:46.495147+00:00"
event_type: "other"
sentiment: "neutral"
materiality_score: 0.2
calibrated_materiality_score: 0.2
confidence: "high"
source: SEC EDGAR
---

# Milestone Pharmaceuticals sets June 10, 2025 as annual meeting date; record date April 15

## Summary
- 2025 annual meeting scheduled for June 10, 2025; record date for voting is April 15, 2025.
- Shareholder proposals under Rule 14a-8 must be received by the company secretary by March 29, 2025.
- Proposals under Quebec Business Corporations Act and company by-laws due by April 15, 2025.
- Universal proxy rule notice for director nominations must be provided by April 11, 2025.

## SEC filing metadata
- accession: 0001104659-25-025547
- form_type: 8-K
- ticker: MIST
- cik: 0001408443
- company_name: Milestone Pharmaceuticals Inc.
- filed_at: 2025-03-19T23:59:59+00:00
- event_type: other
- sentiment: neutral
- materiality_score: 0.2
- calibrated_materiality_score: 0.2
- confidence: high
- sec_items: 5.08
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1408443/000110465925025547/0001104659-25-025547-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1408443/000110465925025547/tm259776d1_8k.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001104659-25-025547
- JSON: https://secwatch.observer/filing/0001104659-25-025547.json
- Plain text: https://secwatch.observer/filing/0001104659-25-025547.txt

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.